Equity
€2,000 ▼ 94.8%
Flocarmed paid out €56,306 in dividends. That is 288% of the 2025 profit.
Flocarmed
Lifetime
4 annual accounts with figures on one time axispeak €34,984 (2024)
€29,150▼ 16.7%
peak €24,657 (2024)
€19,524▼ 20.8%
peak €38,782 (2024)
€2,000▼ 94.8%
€76,546▲ 310%
Board1 name since 2022
1 director
Documentsfilings and deeds
28-05-202664 days before the deadline
2025micro format
Gross margin from €34,984 to €29,150Dividend €56,306Equity from €38,782 to €2,000Debts from €18,664 to €76,546Cash from €27,647 to €57,333
Key points
from the 2025 annual accountsTurnover
≈ €91,000 estimated
The micro format states no turnover.
Debts
€76,546 97% of the balance sheet
Suppliers 2%Taxes and wages 12%Other 86%
Of this, €76,504 falls due within a year.
Liquidity
0.96 was 2.80 in 2024
Short-term debts rose from €18,631 to €76,504.
Filings
4 annual accounts 1 late
The 2024 accounts came 12 days late. The other three were filed on time.
Position in the sector
€2,000
Less equity than 94% of companies in human health. Sector median €125,045 · 21,332 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,156 companies had the same profile as Flocarmed has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,156 companies, not a prediction for Flocarmed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0785951210
Incorporation
Founding capital of €2,000, 100 shares · Founder: · Appointment: (director) · published on 16-05-2022 · Gazette deed
First establishment
Centre Médical du Bord de Meuse, Rue Charles Lamquet 127, Namur
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Flocarmed Profondeville | €78,546 | €29,150 | 2.5% | - |
| CABINET NATACHA LANGELET Charleroi | €74,234 | €31,405 | -13.6% | - |
| CMSD Attert | €77,321 | €28,239 | 46.0% | - |
| DOCTEUR SOPHIE RAPPAZZO Esneux | €79,139 | €30,102 | 20.2% | - |
| Dr. Nathalie Delwiche Genk | €81,158 | €27,021 | 72.1% | - |
| DR. EVY GOOSSENS Kalmthout | €89,844 | €31,597 | 95.3% | - |
| Dr. Anne Claessen Brasschaat | €73,032 | €31,081 | 98.9% | - |
These companies have the same main activity as Flocarmed: general medical practice (NACE 86210). They are comparable in size and age: total assets between €73,000 and €89,800, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 12-05-2022Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.331.341.2535100 Namur, since 12-05-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 18-02-2025
Annual accounts 2025
- €78,546▲ 36.7%
- Filing
- Filed on 28-05-2026, 64 days before the end of the filing period
Insights on Flocarmed
Flocarmed files the micro format. That format states no turnover. The gross margin rose from €9,322 in 2022 to €29,150 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Flocarmed
- What is the company number of Flocarmed?
- The company number of Flocarmed is 0785.951.210. The VAT number is the same number with BE in front: BE 0785.951.210.
- Where is Flocarmed based?
- The registered office is at Rue des Fonds 103, 5170 Profondeville.Company details
- What does Flocarmed do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Flocarmed?
- Flocarmed is a private limited company (BV).
- When was Flocarmed founded?
- Flocarmed was founded on 12-05-2022.
- Is Flocarmed still active?
- Yes, Flocarmed is an active enterprise in the KBO register.
- What is the turnover of Flocarmed?
- The turnover in financial year 2025 is ≈ €91,000. This figure is estimated from the gross margin of €29,150 and 48 comparable companies (NACE 86). It probably lies between €66,000 and €130,000.Financials
- Is Flocarmed profitable?
- In financial year 2025, Flocarmed made a profit of €19,524.
- Where can I find the annual accounts of Flocarmed?
- Flocarmed filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Flocarmed due?
- Flocarmed must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.